Innovative Strategies in addressing the HIV, Hepatitis C and Overdose Crisis for Drug Users

Innovations in medical science and public health can make a difference in stemming the effects of HIV, Hepatitis C and overdose in our community.  Come learn about these issues and new strategies that aim to prevent these epidemics in our community.  Join HIPS, the National Institute of Health, and the Institute of Human Virology at the University of Maryland Baltimore in celebrating of the launch of ANCHOR, a groundbreaking collaboration to study the effects of comprehensive harm reduction, Hepatitis C treatment, HIV prevention, and Opioid Substitution therapy on the lives of people who inject drugs.  


Invited Speakers:

·      Michael Kharfen, Senior Deputy Director, DC Department of Health

·      Cyndee Clay, Executive Director, HIPS

·      Henry Masur, MD, Chief, Critical Care Medicine, National Institutes of Health

·      Travis Gayles, MD, Chief Medical Officer for HAHSTA and Division Chief for STD-TB Control, DC Department of Health

·      David Sternberg, Clinical Services Manager, HIPS

·      Elana Rosenthal, MD, Co-Director, DC Partnership for HIV/AIDS Progress, University of Maryland


April 26, 2017



HIPS Center for Health and Achievement

906 H Street, NE

Washington, DC 20011

Refreshments will be served, reception to follow program

April 26, 2017 at 6pm - 8:30pm
Cyndee Clay
906 NE H St
Washington, DC 20002
United States
Google map and directions
Cyndee Clay · · 2022328150

Who's RSVPing

Sorry, this event is sold out.

Showing 59 reactions

Please check your e-mail for a link to activate your account.